needle for semaglutide Hims? Hers? It's Novo Nordisk's Market Now These highlights do not include

We're glad you're here

Tirzepatide received FDA approval for type 2 diabetes in May 2022 and for chronic weight management in November 2023, following extensive clinical evaluation through the SURPASS and SURMOUNT trial programs

While less impactful on overall weight loss compared to GLP-1 agonists like semaglutide, Orlistat provides a valuable option for individuals who may benefit from reduced fat absorption, particularly those who struggle with high-fat dietary patterns

Ex vivo antioxidant capacities of fruit and vegetable juices: Potential in vivo extrapolation

A dual-action medication (GLP-1 and GIP) that offers highly effective weight loss and metabolic regulation for those who need a more powerful approach